← Leaderboards
Michael Bentley Berger
Plakous Therapeutics, Inc.
$2,861,038
Attributed
$3,623,857
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,623,857 · 1
By mechanism
R44$3,623,857 · 1
Top collaborators
- Michael Paul Francis2 shared
Most similar at Plakous Therapeutics, Inc.
Same institution · by research overlap
- Seth Tomblyn$224,998
Others in their field
Other Emerging Leaders on “Infection Prevention”
- Kimberly Smith · Ppd Development Lp$115,671,664
- Yunda Huang · Fred Hutchinson Cancer Center$74,099,786
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Leonard Freedman · Leidos Biomedical Research, Inc.$65,587,215
- Bambra Strokes · Ppd Development Lp$65,000,267
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$27,369,420
Research focus
Infection PreventionInflammationDoseFetalHistologicGrowth FactorCytokineDisease ModelEmergency SituationFeedingGastrointestinalBiological Response Modifier TherapyBirthAntibioticsAnti-Inflammatory AgentsAcuteAffectDeglutitionCell CountAmniotic FluidCell Differentiation ProcessCellsChemokineInflammatory
Grant awards (4)
IND Enabling Studies and Manufacturing Scale Up of Human Placental Extract to Prevent Surgical Necrotizing Enterocolitis$976,322
R44 · FY2025 · HD · contact PI
IND Enabling Studies and Manufacturing Scale Up of Human Placental Extract to Prevent Surgical Necrotizing Enterocolitis$1,121,897
R44 · FY2024 · HD · contact PI
Development of a human placental extract for the prevention of necrotizing enterocolitis in premature babies$755,655
R44 · FY2022 · HD · contact PI
Development of a human placental extract for the prevention of necrotizing enterocolitis in premature babies$769,983
R44 · FY2021 · HD · contact PI